Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA PFIZER GSK PHARMA/
PFIZER
 
P/E (TTM) x 63.3 39.5 160.5% View Chart
P/BV x 19.2 6.2 311.2% View Chart
Dividend Yield % 1.6 1.6 100.1%  

Financials

 GSK PHARMA   PFIZER
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
PFIZER
Mar-23
GSK PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,6844,662 36.1%   
Low Rs1,2313,407 36.1%   
Sales per share (Unadj.) Rs191.9530.0 36.2%  
Earnings per share (Unadj.) Rs35.9136.4 26.3%  
Cash flow per share (Unadj.) Rs39.8159.4 24.9%  
Dividends per share (Unadj.) Rs32.0070.00 45.7%  
Avg Dividend yield %2.21.7 126.6%  
Book value per share (Unadj.) Rs102.9701.0 14.7%  
Shares outstanding (eoy) m169.4145.75 370.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.67.6 99.7%   
Avg P/E ratio x40.629.6 137.3%  
P/CF ratio (eoy) x36.725.3 144.9%  
Price / Book Value ratio x14.25.8 246.1%  
Dividend payout %89.251.3 173.8%   
Avg Mkt Cap Rs m246,858184,576 133.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9503,317 179.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51724,248 134.1%  
Other income Rs m1,0071,011 99.6%   
Total revenues Rs m33,52425,258 132.7%   
Gross profit Rs m8,0338,420 95.4%  
Depreciation Rs m6581,055 62.3%   
Interest Rs m18135 13.4%   
Profit before tax Rs m8,3648,240 101.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2882,001 114.3%   
Profit after tax Rs m6,0766,239 97.4%  
Gross profit margin %24.734.7 71.1%  
Effective tax rate %27.424.3 112.6%   
Net profit margin %18.725.7 72.6%  
BALANCE SHEET DATA
Current assets Rs m24,94324,933 100.0%   
Current liabilities Rs m13,2646,574 201.8%   
Net working cap to sales %35.975.7 47.4%  
Current ratio x1.93.8 49.6%  
Inventory Days Days9793 104.1%  
Debtors Days Days2162 9,454.4%  
Net fixed assets Rs m6,98813,780 50.7%   
Share capital Rs m1,694458 370.3%   
"Free" reserves Rs m15,73531,616 49.8%   
Net worth Rs m17,43032,073 54.3%   
Long term debt Rs m00-   
Total assets Rs m31,93039,031 81.8%  
Interest coverage x462.662.1 744.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.6 163.9%   
Return on assets %19.116.3 116.9%  
Return on equity %34.919.5 179.2%  
Return on capital %48.126.1 184.2%  
Exports to sales %02.8 0.0%   
Imports to sales %48.10 138,750.2%   
Exports (fob) Rs mNA688 0.0%   
Imports (cif) Rs m15,6308 186,070.8%   
Fx inflow Rs m1,622688 235.8%   
Fx outflow Rs m15,6308 186,070.8%   
Net fx Rs m-14,008679 -2,061.9%   
CASH FLOW
From Operations Rs m4,8423,557 136.1%  
From Investments Rs m8,079-361 -2,240.9%  
From Financial Activity Rs m-15,433-3,458 446.3%  
Net Cashflow Rs m-2,512-262 960.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.3%  
Indian inst/Mut Fund % 11.6 18.2 63.7%  
FIIs % 2.9 3.0 96.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 36.1 69.3%  
Shareholders   114,663 112,456 102.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Pfizer Share Price Performance

Period GSK Pharma Pfizer S&P BSE HEALTHCARE
1-Day 2.78% -1.11% 0.88%
1-Month -12.32% -5.83% -4.09%
1-Year 54.30% 22.59% 59.00%
3-Year CAGR 12.05% -0.80% 18.97%
5-Year CAGR 8.92% 6.06% 19.20%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.